Regulatory and Compliance Updates news

20 July 2026

GSK Bexsero: EMA accepts submission to add single-dose booster for 10+ years

Phase 3b data indicate a single Bexsero booster at age 10+ boosts immunity in those primed in infancy; full study results will be presented at IPNC in September.
17 July 2026

European Commission Electrification Action Plan and ETS review

Sets a 46% electrification target by 2040, reforms the EU ETS to drive investment and stability, and mobilises funding and regulatory measures to lower electricity costs and speed grid rollout.
16 July 2026

Takeda: Zasocitinib achieves high, consistent clearance at hard-to-treat psoriasis sites

Phase 3 secondary data show ~75% scalp and ~70% palmoplantar clearance at week 16; significant nail improvement; responses sustained to week 24; common AEs: URTI, nasopharyngitis, acne.
16 July 2026

Gasunie positions the Netherlands as Europe’s CO₂ hub

Five connected CCS projects (Porthos, Aramis, CO₂next, DRC, DSC) will capture, transport and store CO₂ under the North Sea and link industry across the Netherlands, Belgium and Germany.
16 July 2026

Merck’s LIPFENDRA — first FDA‑approved once‑daily oral PCSK9 inhibitor

Oral macrocyclic peptide enlicitide (20 mg) lowers LDL-C ~56–59% at week 24 in Phase 3 trials; approved as adjunct to diet and exercise for adults with hypercholesterolemia, including HeFH.
15 July 2026

Repsol, Toyota, BMW and Bosch pilot cars on 100% renewable gasoline

Six-month Spanish trial uses existing cars, 100% renewable gasoline and digital tracking to demonstrate drop-in fuel scalability without new vehicles or infrastructure.

The right choices in the European chemical industry

Save time with chemXplore Alpha

Learn more

Next →